Login
Fresenius Medical Care NYSE: FMS
Fresenius Medical Care Corp. is a Germany-based firm specializes in treatment and services for patients with chronic kidney failure
| Name | Fresenius Medical Care |
| Ticker | FMS |
| Exchange | NYSE |
| Sector | Health Care |
| Industry | Kidney Failure |
| Price | 40.86 |
| 52W Low/High | 29.21 / 46.55 |
| Market cap | 24 B |
| 1Y Total Return |
26.81%
Strong |
| 1Y Volatility |
31.46%
Low Risk |
Relative Strength Index : Attempt to identify overbought (above 80) and oversold (below 20) conditions
Fresenius Medical Care Corp. is a Germany-based firm specializes in treatment and services for patients with chronic kidney failure
Details
| Ticker | FMS |
| Name | Fresenius Medical Care |
| ISIN | DE0005785604 |
| CUSIP | |
| Exchange | NYSE |
| Sector | Health Care |
| Industry | Kidney Failure |
| Country | Germany |
| Currency | U.S. Dollar |
Share as of 10/23/20
| Close Price | 40.86 |
| 52W Low/High | 29.21 / 46.55 |
| Market cap | 24 B |
| 1Y Total Return |
26.81%
Strong |
| 1Y Volatility |
31.46%
Low Risk |
| Beta | 1.97 |
| PE (trailing) |
20.64
Average |
| 12M Dividends | 0.655 |
| Last Dividend Date | 8/28/20 |
| Dividend Yield | 1.60% |
Fin. Strength
| Net Profit Margin | 6.9% |
| Cash from Op. / Cur. Liabilities | 0.37 |
| Diluted Earnings / Share | 1.98 |
| ROE | 10.1% |
| ROIC | 8.2% |
| Price / Revenue | - |
| Price / Book | - |
| Price / CF | - |
| Current Ratio | 1.0 |
| Cur.Liabilities / Tot.Liabilities | 0.4 |
| Financial Leverage | 1.15 |
| in Mils USD |
rolling-year up to December
|
||||||
|---|---|---|---|---|---|---|---|
| Income Statement | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
| Revenue |
17,477
|
16,547
|
17,784
|
17,911
|
16,738
|
15,832
|
|
| Gross Profit |
5,396
|
5,155
|
6,004
|
5,780
|
5,331
|
4,996
|
|
| R&D |
168
|
134
|
131
|
162
|
140
|
122
|
|
| EBITDA |
3,685
|
3,666
|
2,866
|
3,155
|
2,877
|
2,824
|
|
| Operating Income |
2,196
|
2,964
|
2,295
|
2,573
|
2,295
|
2,230
|
|
| Net Income exc. Extra |
1,200
|
1,982
|
1,280
|
1,243
|
1,029
|
1,045
|
|
| per Share | |||||||
| Diluted avg Shares |
-
|
-
|
-
|
-
|
-
|
-
|
|
| EPS exc. Extra |
1.98
|
3.23
|
2.08
|
2.03
|
1.69
|
1.73
|
|
| Dividend |
0.66
|
0.66
|
0.36
|
0.44
|
0.44
|
0.53
|
|
| Div. Yield (an.) |
1.60%
|
1.82%
|
0.68%
|
1.05%
|
1.07%
|
1.36%
|
|
| Balance Sheet | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
| Total Assets |
32,935
|
26,242
|
24,025
|
26,934
|
25,533
|
25,447
|
|
| Cash, Eq & Invt ShortTerm |
1,008
|
2,146
|
978
|
747
|
550
|
634
|
|
| Total Current Assets |
7,165
|
7,847
|
6,374
|
7,314
|
6,985
|
6,725
|
|
| Total Non-Current Assets |
25,770
|
18,395
|
17,651
|
19,620
|
18,549
|
18,722
|
|
| Intangibles |
15,444
|
12,891
|
12,787
|
14,514
|
13,863
|
13,952
|
|
| Total Liabilities |
19,707
|
13,340
|
13,197
|
14,236
|
14,009
|
14,594
|
|
| Total Current Liabilities |
7,007
|
6,268
|
5,300
|
5,037
|
4,186
|
3,477
|
|
| Long Term Debt |
12,700
|
7,072
|
7,897
|
9,198
|
9,823
|
11,117
|
|
| Shareholder equity |
11,958
|
11,758
|
9,820
|
10,809
|
9,887
|
9,443
|
|
| Cash Flow | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
| Cash from Operations |
2,567
|
2,062
|
2,192
|
2,140
|
1,960
|
1,861
|
|
| Depreciation |
1,593
|
725
|
735
|
776
|
717
|
699
|
|
| Cash from Investing |
-3,286
|
-245
|
-992
|
-1,379
|
-1,001
|
-2,691
|
|
| Capex |
1,113
|
1,003
|
841
|
1,012
|
936
|
920
|
|
| Cash from Financing |
-467
|
-682
|
-799
|
-585
|
-1,008
|
805
|
|
| Stock Issued |
-584
|
10
|
-10
|
49
|
94
|
107
|
|
| Debt (LT) Issued |
319
|
161
|
-308
|
-234
|
-331
|
1,233
|
|
| Free Cash Flow |
3,765
|
1,486
|
1,515
|
1,453
|
1,578
|
890
|
|
| Ratios | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
| Net Profit Margin |
6.9%
|
12.0%
|
7.2%
|
6.9%
|
6.2%
|
6.6%
|
|
| NCFO / Op.Income |
116.9%
|
69.6%
|
95.5%
|
83.2%
|
85.4%
|
83.5%
|
|
| Current Ratio |
1.0
|
1.3
|
1.2
|
1.5
|
1.7
|
1.9
|
|
| Financial Leverage D/E |
1.15
|
0.64
|
0.76
|
0.79
|
0.87
|
1.01
|
|
| Return on Capital Avg |
8.2%
|
11.6%
|
8.5%
|
6.3%
|
6.3%
|
6.8%
|
|
| Return on Shareholder Equity |
10.1%
|
18.4%
|
12.9%
|
12.0%
|
10.7%
|
11.2%
|
|
Fundamentals
No documents are available for the moment, please check back soon, or save the asset to be notified when documents are available